Works matching IS 25094254 AND DT 2024 AND VI 8 AND IP 6


Results: 16
    1
    2
    4
    5
    6
    7
    8
    9
    10

    Estimation of the Clinical, Economic, and Social Burden of Stage IV Non-Small Cell Lung Cancer in Mexico.

    Published in:
    PharmacoEconomics - Open, 2024, v. 8, n. 6, p. 869, doi. 10.1007/s41669-024-00514-6
    By:
    • Añorve Bailon, Denisse;
    • Picó-Guzmán, Javier;
    • Cifuentes, Sergio;
    • Trejo, Rogelio;
    • Rodríguez Cid, Jeronimo;
    • Juarez-Vignon Whaley, Juan Jose;
    • Heredia Zepeda, Alan Alexis;
    • Gerson, Raquel;
    • Camacho-Limas, Christian Patricio;
    • Martínez-Herrera, José Fabián;
    • Molina, Diana Bonilla;
    • Camarín Sánchez, Efraín;
    • Shveid Gerson, Daniela
    Publication type:
    Article
    11
    12

    Economic Impact of Bladder Cancer in the USA.

    Published in:
    PharmacoEconomics - Open, 2024, v. 8, n. 6, p. 837, doi. 10.1007/s41669-024-00512-8
    By:
    • Clark, Otavio;
    • Sarmento, Tulio;
    • Eccleston, Anthony;
    • Brinkmann, Julia;
    • Picoli, Renato;
    • Daliparthi, Vamsi;
    • Voss, Jorine;
    • Chandrasekar, Sanjana;
    • Thompson, Allison;
    • Chang, Jane
    Publication type:
    Article
    13

    Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018 to 2022: Methodological Critiques on Manufacturers' Submissions and a Comparison between Manufacturer and Canadian Agency for Drugs and Technologies in Health (CADTH) Analyses

    Published in:
    PharmacoEconomics - Open, 2024, v. 8, n. 6, p. 823, doi. 10.1007/s41669-024-00511-9
    By:
    • Mirzayeh Fashami, Fatemeh;
    • Tarride, Jean-Eric;
    • Sadeghirad, Behnam;
    • Hariri, Kimia;
    • Peyrovinasab, Amirreza;
    • Levine, Mitchell
    Publication type:
    Article
    14
    15
    16